// App-Quantinova.ai

3298 : Mesenchymal Stromal Cells (MSCs) Experience in France to Prevent Graft Failure after Hematopoietic Stem Cell Transplantation: A Retrospective Study from the MSCs/CTL Group of the Francophone Society SFGM-TC

Researchers

Presenter

  • Lea Bosdure

Principal Investigators

  • Jean-Hugues Dalle

  • Catherine Paillard

  • Mony Fahd

  • Valerie Coiteux

  • Nadine Petitpain

  • Danile Bensoussan

  • Jacques-Olivier Bay

  • Marie Thrse Rubio

  • Cecile Pochon

Medical Centers

  • CHU de Besancon, Besancon University, Besancon, France

  • Robert Debre Hospital, GH APHP Nord Université de Paris, Hematology and Immunology Department, Paris, France

  • Statistical department, Strasbourg University Hospital, Strasbourg, France

  • hematology and immunology department, Robert Debré Hospital, GH APHP Nord Université de Paris, Paris, France

  • Dermatology Department, CHRU Lille, Lille, France

  • CHRU Nancy, Centre Régional de Pharmacovigilance, Nancy, France

  • Centre Hospitalier Universitaire De De Nancy, Vandeouvre Les Nancy, FRA

  • Service d'Hematologie Clinique et de Therapie Cellulaire, CHU, Universite d'Auvergne, EA7453, CIC501, Clermont-Ferrand, FRA

  • CHU Nancy Hopital Brabois, Vandoeuvre Les Nancy, France

  • CHRU de Nancy - Université de Lorraine, NANCY, FRA

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Aplastic anemia

  • Anemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

  • Mesenchymal stem cells

  • Soluble Complement 5b-9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved